Safety is of high significance at TICEBA. On the one hand, we are orienting ourselves towards German and European standards and laws. On the other hand, our efficient quality management, the modern laboratory with the latest technology as well as our long lasting experience are contributing to the safety of your stem cells.

TICEBA - Our promise - Picture 01TICEBA - Our promise - Picture 02


Our organizational structure guarantees an efficient cooperation of all employees and therefore contributes to the assurance of the required quality. Our main focus is on the highest possible flexibility and good service, which enables us to offer our high-quality biological preventive measure "Back-up". In addition, a continuous improvement process contributes to the optimization of the efficiency of our quality management. This is the corner stone for the high level of satisfaction of our customers.

Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcers (CVU), diabetic foot ulcers (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.


Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.